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Abstract Circular dichroism (CD) and 2-dimensional NMR 
were used to study the solution conformation of conantokin-T 
(Con-T), a small peptide toxin found in the venom of fish-hunting 
cone snails, and its Glu-substituted analog. Con-T lacks disulfide 
bonds but contains many y-carboxyglutamic acids (Gla), a post-
translationally modified residue. Our results show that Con-T 
adopts an a-helical conformation in aqueous solution even in the 
absence of calcium. Glu replacements diminish both helicity and 
function of Con-T. The helical content of Con-T is higher than 
most natural helical peptides of this length in aqueous solution. 
The sequence of this small toxin incorporates several known 
elements that stabilize a-helical structure in peptides. Gla 
residues form several salt bridges that stabilize helical conforma-
tion of Con-T. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The venom of the cone snails (Conus) contains an extraor-
dinary variety of small pharmacologically active peptides [1]. 
The targets of these toxins include voltage-sensitive calcium 
channels, sodium channels, acetylcholine receptors, vasopres-
sin receptors, and JV-methyl-D-aspartate (NMDA) receptors in 
the neuromuscular system [2]. Conantokins are peptide toxins 
found in the venom of fish-hunting Conus. Unlike other toxins 
from Conus venoms, conantokins lack cysteine residues [3]; 
they incorporate, instead, numerous y-carboxyglutamic acid 
(Gla), a post-translationally modified residue. Conantokin-G 
(Con-G) is a 17-amino-acid peptide, containing five Gla resi-
dues, found in the venom of C. geographus. Conantokin-T 
(Con-T), which contains four Gla residues, is a 21-residue 
peptide isolated from C. tulipa venoms, sharing about 40% 
sequence homology with Con-G. Both Con-G and Con-T in-
duce a sleeping effect in young mice but hyperactive behaviour 
in old mice when administered by intracranial injection [2]. It 
was suggested that conantokins form helical structure upon 
chelation of calcium ion by the Gla residues [4]. Calcium 
binding has been the primary function attributed by y-carbox-
yglutamic acid residues in proteins. One possible role is Ca2+-
mediated intrachain or interchain interactions with other Gla 
residues. Gla residues can also mediate binding to membrane 
surface through Ca2+ ion bridges with the anionic phosphate 
head groups [5]. Although several studies on Gla residues, 
mostly concentrating on the blood-clotting proteins, have 
emerged recently [6,7], little is known about the role of Gla 
residues in conantokins. In order to understand the impor-
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tance of Gla residues in these molecules, we replaced all Gla 
residues in Con-T by Glu (for sequence see Fig. 1), and in-
vestigated the effect on the structure and function. We report 
here the circular dichroism (CD) and NMR studies of the 
Con-T and its Glu analog. We also examined the effect of 
Con-T and its Glu analog on the NMDA receptor in rat 
hippocampal CA1 neurons by electrophysiological techniques. 
The substitution of all Gla residues by Glu not only reduces 
the helicity, but also diminishes the NMDA antagonism of 
Con-T. 
2. Materials and methods 
2.1. Sample preparation 
Con-T and Con-ET were synthesized using an Applied Biosystems 
430A peptide synthesizer, using standard F-moc Chemistry. Crude 
peptides were purified by reverse-phase HPLC on a Vydac Qs 
semi-preparative column (300 A, 10 mmX25 cm) with a gradient of 
10-40% acetonitrile in 0.1% trifluoroacetic acid. The molecular weight 
of purified peptides was confirmed by FAB-Mass spectroscopy. 
2.2. Circular dichroism measurements 
CD spectra were run on an Aviv model 62A DS spectropolarimeter. 
The wavelength was checked by a two-point calibration with D-10-
camphorsulfonic acid [8]. The concentration of stock solutions was 
determined by using the absorption of Tyr at 275.5 nm in 6 M gua-
nidine hydrochloride for Con-T and Con-ET [9]. For Ca2+-free CD 
measurements, peptides were treated with chelex-100 (Sigma) for 1 h 
and passed through a 0.45 mm filter (Lida, WI) to remove Ca2+ ions. 
The fraction of helix was obtained from the relationship / = [0]obs/ 
[8]max, [6](,bs is the mean residue ellipticity observed at 222 nm, and 
[8]max = (n—4/n)[8]°o = the maximal mean residue ellipticity value for 
chain length n, where [0]=° = —40000 deg-cm2/dmol [10]. 
2.3. Sedimentation equilibrium 
Sedimentation equilibrium analysis was performed using a Beck-
man XL-A analytical ultracentrifuge operating between 40000 and 
55 000 rpm. The partial specific volume (vbar) was calculated as sug-
gested by Laue et al. [11], the value was 0.71 ml/g for Con-T peptide. 
The solvent density was taken as 1.006 g/ml. Data were fit to a single 
exponential using NONLIN [12]. Peptide concentrations of 150, 75, 
and 30 uM were analyzed at 22°C. Buffer consisted of 10 mM potas-
sium phosphate, 100 mM NaCl, pH 7.0. 
2.4. lH NMR spectroscopy 
NMR spectra were recorded on a Bruker DMX-600 spectrometer 
equipped with an X32 computer at 25°C. Time-proportional phase 
incrementation (TPPI) [13] was used to acquire phase-sensitive NO-
ESY [14], DQF-COSY [15], and TOCSY [16] spectra. Typical 2D data 
sets contained 512 FIDs with 2K data points each, requiring 32-64 
scans/FID, a spectral width of 6204 Hz, and a recycle delay of at least 
1.5 s. The acquired data were processed using UXNMR (Bruker). The 
peptide samples were prepared at a concentration of approximately 
5 mM in 90% H2O/10% D20. 
2.5. Slice preparation and intracellular recordings 
Hippocampal slices (500 mm thick) were isolated from Sprague-
Dawley rats (120-150 g) and used for intracellular recording as re-
ported [17]. A submerged recording chamber was used and the super-
fusing artificial cerebral spinal fluid (ACSF) solution was maintained 
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at 32±1°C. The composition of the ACSF solution was (in mM): 
NaCl 117, KC1 4.7, CaCl2 2.5, MgCl2 1.2, NaH2P04 1.2 and glucose 
11 (pH 7.4), bubbled with a mixture of 95% 02 and 5% C02. The 
chamber consisted of a circular well of a low volume (1-2 ml) and was 
constantly perfused at a rate of 2-3 ml/min. Intracellular recordings 
were made from CA1 pyramidal neurons using glass microelectrode 
filled with 3 M potassium acetate (80-100 MW) as described previ-
ously [18]. Electrical signals were recorded using an Axoclamp-2B 
amplifier (Axon Co.), and a IBM-486-based microcomputer with 
pCLAMP software (version 6.0.2, Axon Co.) was used to acquire 
and analyze the data. 
3. Results 
3.1. Con-T adopts helical conformation in the absence of 
calcium ions 
The peptide absorption bands in the far UV region become 
optically active in the asymmetric environment of a-helix, 
producing a characteristic double minima at 222 and 208 
nm and a maximum at 195 nm [19]. Fig. 1 shows the CD 
spectra of conantokins and their analogs at 25°C in aqueous 
solution. Con-T exhibits a typical helix spectrum with about 
75% helicity. Although the helix content is not as high as its 
wild type, Con-ET still shows considerable helical structure in 
aqueous solution. It should be noted that all measurements 
were carried out in the absence of calcium ion. Chelex 100 was 
used to remove trace metal ions. However, addition of calci-
um to Con-T and Con-ET only affects their CD spectra 
slightly. Recent studies by Castellino and co-workers [20] 
found that addition of Ca2+ increases the helical content of 
Con-G substantially whereas the existing helical structure of 
Con-T increases only by a small amount. This is different 
from the observation by Chandler and co-workers [21], where 
they found that Ca2+ titration did not affect the solution 
conformation of Con-G at all. We think this apparent discrep-
ancy may be due to the pH employed. The ionization state of 
y-carboxyl groups of Gla greatly affects its calcium binding 
ability. 
There is a known tendency of a-helices to associate inter-
molecularly, especially for those peptides with amphipathic 
sequences. Although the sequences of conantokins do not 
reveal a strong tendency to form a hydrophobic face in helical 
wheel projections, they show a clustering of Gla residues on 
one side. Conantokins may form stable a-helices as a conse-
on 
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Fig. 2. Fingerprint region of the TOCSY spectrum of Con-T at 
25°C. The mixing time is 90 ms. Each intraresidue spin system is 
connected with solid lines and labeled by standard one letter sym-
bols for the amino acids (except y for Gla) and the residue number 
in the sequence. 
Wavelength (nm) 
Fig. 1. The CD spectra of Con-T and Con-ET. The measurements 
reported here were carried out in 10 mM KF, pH 5, at 25°C, using 
a 1 mm path length cuvette. Each spectrum is an average of three 
scans measured with a 0.5 nm step size. 
quence of intermolecular association of this highly charged 
Gla face, mediated by calcium ion [4]. Thus, it is essential 
to verify the molecularity of these peptides. The dependence 
of ellipticity on peptide concentration (up to 400 u.M) in the 
C.H. Lin et allFEBS Letters 407 (1997) 243-248 245 
Fig. 3. a: CaH-amide region of the NOESY spectrum. The mixing time is 250 ms. A series of cross peaks between Ca proton and peptide NH 
are connected by solid line and indicated by the sequence numbers of the pair of adjacent residues. Dashed line connects those medium range 
NOEs; daN(i, i+3) (underlined), da^(i, i+2) and daN(i, i+4) (boxed), b: Schematic summary of NOE connectivities for Con-T. Filled squares 
and solid lines indicate unambiguous NOEs. Empty squares and dashed lines indicate possible NOEs where chemical shift degeneracy interferes 
with identification. 
absence and presence of calcium ions has been monitored by 
CD at 222 nm (data not shown). The resulting straight line 
reveals that no aggregation occurred in the solution over the 
range examined [22]. We have also measured its apparent 
relative molecular mass (Mr) in sedimentation equilibrium ex-
periments, using light absorption optical systems. A plot of 
the In (absorbance) versus r2 shows linear dependence with no 
apparent systematic residuals (data not shown), indicating 
that the peptide forms a unique species in solution with the 
molecular weight in the monomeric range. Con-T also exhibits 
a strong dependence on temperature; its helix content drops 
from about 95% at 4°C to 28% at 75°C. Thermal melting of 
this peptide does not yield a sigmoidal curve, which is ex-
pected for most dimers or multimers that exhibit cooperative 
behavior during thermal unfolding. This also supports that 
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Fig. 4. 
tion of 
Effects of Con-T and Con-ET on the pharmacological isola-
EPSPXMDA o n the hippocampal CA1 neurons. 
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Fig. 5. a: Schematic illustration of the helix stabilization factors in conantokin-T. b: Stereo diagram showing the relative position of those 
charged side chains in a helical model of conantokin-T. The charged side chains that have potential to form salt-bridges or interacting with he-
lix dipole are indicated by dotted van der Waals surfaces in different color; red, Gla; pink, Glu; dark blue, Lys; light blue, Arg. The model is 
generated on a IRIS workstation using the Insight II program (Biosym Technologies, Inc.). 
helix formation in this peptide is not due to intermolecular 
association. 
3.2. NMR studies on Con-T 
To further characterize the helical conformation of Con-T, 
2D NMR analysis has been carried out for this peptide. As-
signments of the proton spectrum of Con-T were done by 
following the standard sequential procedure [23]. The finger-
print region of the TOCSY spectrum was used to identify the 
intraresidue spin systems (Fig. 2). The side chains of Gla 
residues are easily recognized in this region, since the Cy pro-
ton of Gla shifts further down field (3.33-3.47 ppm) compared 
to the Cy proton of Glu, due to the presence of an extra 
carboxyl group. The fingerprint region of the NOESY spec-
trum is shown in Fig. 3a. Continuous cross peaks between 
adjacent CotH and NH can be identified from the beginning 
of the chain to the end, which are characteristic of the a-helix 
[23], The more stringent signatures of a-helix, such as me-
dium-range doN(i, i+3) and dKN(i, i+4) cross peaks, can also 
be identified in this region of NOESY spectrum. The presence 
of some weak dan(i, i+2) cross peaks may indicate an equili-
brium between 3i0 and a-helical forms. The other character-
istic sequential NOEs, such as dNN, dßN and daß(i, i+3), are 
observed as well (Fig. 3B). Compared to other isolated pep-
tides, studied by NMR in aqueous solution [24,25], the NOE 
peaks observed in Con-T are clearer and thorough. All of 
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these sequential NOE connectivities confirm the presence of a 
stable helix of Con-T in aqueous solution. 
3.3. The antagonism of Con-T and Con-ET on the NMDA 
receptor 
The effect of Con-T and Con-ET on the excitatory synaptic 
transmission is studied in the CA1 region of rat hippocampal 
slices using intracellular recording techniques. We showed pre-
viously that superfusion of Con-T specifically and irreversibly 
decreased the pharmacologically isolated NMDA receptor-
mediated excitatory postsynaptic potential (EPSPNMDA) in a 
concentration-dependent manner [18]. This is due to an inter-
action of Con-T with the glutamate binding site and the poly-
amine recognition site of NMDA receptors. Here, we compare 
the effect of Con-T and its Glu analog on the NMDA recep-
tor. Fig. 4 shows the percentage of inhibition at different 
concentrations of Con-T and Con-ET. The results indicate 
that Glu substitution decreases the inhibitory effect of Con-
ET. The apparent IC5o of Con-T and Con-ET against E P -
SPNMDA is approximately 23 nM and 100 nM, respectively. 
4. Discussion 
Our CD and NMR studies show that Con-T adopts helical 
conformation even in the absence of calcium. The helix for-
mation in Con-T in the absence of calcium ions must arise 
from factors other than chelation of Ca2+ by Gla residues. 
Although many peptides of this size are found to fold into a-
helical conformation [26,27], the intrinsic helix propensity of 
amino acid per se is not the sole element for helix formation. 
Helix formation in short peptides frequently depends on the 
combination of several factors, including the side chain-side 
chain interactions, the helix dipole [28], salt-bridges [29], cap-
ping effects [23], and hydrophobic interactions in the case of 
coiled coils [30]. To our knowledge, the helicity of Con-T in 
aqueous solution is higher than most natural peptides of sim-
ilar size. Con-T is a very good model for helix; its sequence 
carries several known elements for de novo design of helical 
structure in peptides [31]. These elements are illustrated in 
Fig. 5a. First, the intrinsic helix propensity of this sequence is 
very high. There are only five residues with a Pa value less 
than 1.00. The average Pa value for any window of four 
residues is greater than 1.00 and the overall average P& value 
is about 1.20 if we use the Pa value of Glu for Gla [32]. 
Second, the N-terminus of this peptide contains many acidic 
side chains, while the C-terminus has many basic ones. Total 
charge of the first four residues at N terminus is —4 while at C 
terminus is +2. These charged groups can stabilize the helix 
through an interaction with helix dipole [28,33]. Third, several 
salt-bridges can be formed. Two i, i+4 salt bridges and five 
i, i+3 salt bridges can be potentially formed by combinations 
among these residues. Fig. 5b shows the relative positions of 
charged residues of Con-T in the helical conformation. The 
charged residues seem to form a 'salt-bridged network' on one 
side of helix. It has been shown that pairs of oppositely 
charged side chains at positions i and i ± 4 (or i ± 3) can sta-
bilize helical conformation in proteins [34] and in model pep-
tides [26,29]. In order to test this possibility in Con-T, we 
investigated the pH dependence of its CD spectra. The state 
of ionization of side chains controls their ability to pair. Thus, 
the structure of Con-T will be highly sensitive to pH if salt-
bridges are important to the stability of the a-helix in this 
peptide. The bell-shaped profile obtained (data not shown) 
is a typical pattern of pH titration for peptides containing 
multiple salt-bridges [26]. Salt-bridges contribute considerably 
to helix formation in Con-T since each salt-bridge is estimated 
to contribute about 0.5 kcal/mol to the stability of helix in the 
isolated peptide model [29], Thus, calcium binding by Gla is 
not a critical determinant for helix formation in Con-T; 
rather the side chain interactions mentioned above play im-
portant roles. Glu substitutions not only decrease the helical 
content of Con-T, but also diminish its inhibition of NMDA 
receptor. It was reported that a-helicity is not sufficient for 
the NMDA antagonism of Con-G [21]. The relationship be-
tween the diminution of function and the loss of helical con-
formation of Con-T by Glu replacements remains unclear at 
this stage. Further studies are necessary to unravel this corre-
lation. 
5. Note added in proof 
An interesting paper describing the structures of Con-T and 
Con-G appeared after the submission of the manuscript. They 
indicate that the 3D structures of conantokins are composed 
of a dynamic mixture of 3i0 and a-helix [SkjœrbEek N, Nielsen 
KJ, Lewis RJ, Alewood P, Craik DJ (1997) J Biol Chem 272, 
2291-2299]. 
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